Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Positron Emission Tomography/computed Tomography (PET/CT)
85%
Infarction
76%
Myocardial Infarction
74%
Acute Myocardial Infarction
52%
Infarct Size
51%
Palmitate
48%
Congestive Heart Failure
46%
Myocardial Metabolism
34%
Oxidative Metabolism
29%
Myocardial Perfusion
29%
Myocardium
29%
Perfusion
26%
Patients with Heart Failure
26%
Functional Recovery
23%
Angiotensin-converting Enzyme Inhibitor (ACEi)
23%
Positron Tomography
22%
Cardiac Transplantation
22%
18F-fluorodeoxyglucose (18F-FDG)
22%
Beta-blockers
21%
Ventricular Enlargement
20%
Carbon-11
20%
Inferior Infarction
18%
Cardiomyopathy
18%
11C-acetate
17%
Metabolism
17%
Captopril
17%
Transplantation
16%
Angina
16%
H215O
16%
Viable Myocardium
16%
Maximal Oxygen Uptake
15%
Left Ventricular Function
15%
Myocardial Ischemia
15%
Exercise Training
15%
Fatty Acid Metabolism
15%
Adrenergic Blockers
15%
Hemodialysis Patients
15%
Tissue Plasminogen Activator (t-PA)
15%
Thrombolysis
15%
Streptokinase
14%
Heart Failure
14%
Coronary Revascularization
13%
Q Wave
13%
Coronary Artery Disease
13%
Glucose Metabolism
13%
Left Ventricular Dysfunction
12%
Left Ventricular Systolic Dysfunction
12%
Patient Management
12%
Disappearance Rate
12%
Heart Transplantation
11%
Medicine and Dentistry
Positron Emission Tomography
100%
Myocardial Infarction
95%
Infarction
74%
Congestive Heart Failure
57%
Heart Muscle Perfusion
50%
Carbon 11
39%
Heart Transplantation
39%
Coronary Artery Disease
33%
Acute Heart Infarction
32%
Palmitic Acid
30%
Myocardium
30%
Angina pectoris
27%
Heart Muscle Metabolism
24%
Aerobic Metabolism
22%
Coronary Vasospasm
22%
Calcium Channel Blocking Agent
17%
Oxygen Consumption
17%
Cardiovascular System
16%
Nifedipine
16%
Dilated Cardiomyopathy
16%
Dipyridamole
15%
Myocardial Disease
15%
Adrenergic Receptor Blocking Agent
15%
Fluorine-18
13%
Heart Muscle Revascularization
13%
Left Ventricular Systolic Dysfunction
11%
Coronary Artery
11%
Oxygen 15
11%
Angina Pectoris
11%
Heart Graft
11%
Thorax Pain
11%
Revascularization
11%
Patient Care
10%
Hypertension
10%
Morbidity
10%
Deterioration
10%
Heart Left Ventricle Function
10%
Glucose
10%
Coronary Vasodilating Agent
9%
Acetic Acid
9%
Fibrinolytic Therapy
9%
Heart Left Ventricle Failure
9%
Allograft
9%
Cardiovascular Disease
9%
Ischemic Heart Disease
9%
Graft Survival
9%
Glucose Metabolism
8%
Acetic Acid C 11
8%
Beta Adrenergic Receptor Blocking Agent
8%
Heart Muscle Ischemia
8%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
95%
Congestive Heart Failure
89%
Infarction
85%
Carbon 11
71%
Acute Heart Infarction
57%
Normal Human
33%
Acetic Acid C 11
32%
Palmitic Acid
31%
Dipeptidyl Carboxypeptidase Inhibitor
29%
Captopril
28%
Coronary Artery Disease
27%
Glucose
27%
Morbidity
26%
Heart Left Ventricle Failure
25%
Nifedipine
24%
Coronary Artery Spasm
22%
Fluorine 18
21%
Heart Muscle Ischemia
18%
Myocardial Disease
17%
Fluorodeoxyglucose
17%
Fatty Acid
16%
Placebo
15%
Fibrinolytic Agent
14%
Oxygen 15
12%
Fluorodeoxyglucose F 18
11%
Left Ventricular Systolic Dysfunction
11%
Dipyridamole
11%
Troponin I
11%
Thorax Pain
10%
Beta Adrenergic Receptor Blocking Agent
10%
Congestive Cardiomyopathy
10%
Clinical Trial
10%
Hypertension
9%
Angina Pectoris
9%
Coronary Vasodilating Agent
9%
Clinical Study
9%
Cardiovascular Disease
9%
Diabetes Mellitus
9%
Mortality Rate
8%
Thrombosis
8%
Streptokinase
8%
Tracer
8%
Ischemic Heart Disease
7%
Ischemia
7%
Adrenergic Receptor Blocking Agent
7%
Calcium Channel Blocker
7%
Thrombocyte Factor 4
7%
Mibefradil
7%
Galectin 3
7%
Biological Product
7%